These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33197567)

  • 1. Can alternative PET reconstruction schemes improve the prognostic value of radiomic features in non-small cell lung cancer?
    Tankyevych O; Tixier F; Antonorsi N; Filali Razzouki A; Mondon R; Pinto-Leite T; Visvikis D; Hatt M; Cheze Le Rest C
    Methods; 2021 Apr; 188():73-83. PubMed ID: 33197567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
    Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
    Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
    Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
    J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
    Zhang N; Liang R; Gensheimer MF; Guo M; Zhu H; Yu J; Diehn M; Loo BW; Li R; Wu J
    Theranostics; 2020; 10(25):11707-11718. PubMed ID: 33052242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment
    Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
    J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep segmentation networks predict survival of non-small cell lung cancer.
    Baek S; He Y; Allen BG; Buatti JM; Smith BJ; Tong L; Sun Z; Wu J; Diehn M; Loo BW; Plichta KA; Seyedin SN; Gannon M; Cabel KR; Kim Y; Wu X
    Sci Rep; 2019 Nov; 9(1):17286. PubMed ID: 31754135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of interim 18F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy.
    Kim N; Kim JS; Geol Lee C
    PLoS One; 2020; 15(7):e0236350. PubMed ID: 32687531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer.
    Mostafa R; Abdelsamie Kandeel A; Abd Elkareem M; Nardo L; Abdelhafez YG
    Nucl Med Commun; 2022 May; 43(5):540-548. PubMed ID: 35190518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis.
    Chen J; Xia J; Huang J; Xu R
    BMC Cancer; 2020 Jun; 20(1):510. PubMed ID: 32493238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer.
    Pfaehler E; Mesotten L; Zhovannik I; Pieplenbosch S; Thomeer M; Vanhove K; Adriaensens P; Boellaard R
    Med Phys; 2021 Mar; 48(3):1226-1238. PubMed ID: 33368399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
    Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
    Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies.
    Shiri I; Rahmim A; Ghaffarian P; Geramifar P; Abdollahi H; Bitarafan-Rajabi A
    Eur Radiol; 2017 Nov; 27(11):4498-4509. PubMed ID: 28567548
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising Candidate Prognostic Biomarkers in [
    Hovhannisyan-Baghdasarian N; Luporsi M; Captier N; Nioche C; Cuplov V; Woff E; Hegarat N; Livartowski A; Girard N; Buvat I; Orlhac F
    J Nucl Med; 2024 Apr; 65(4):635-642. PubMed ID: 38453361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-[
    Manafi-Farid R; Karamzade-Ziarati N; Vali R; Mottaghy FM; Beheshti M
    Methods; 2021 Apr; 188():84-97. PubMed ID: 32497604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
    Lasnon C; Salomon T; Desmonts C; Dô P; Oulkhouir Y; Madelaine J; Aide N
    Ann Nucl Med; 2017 Feb; 31(2):125-134. PubMed ID: 27812791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
    Houdu B; Lasnon C; Licaj I; Thomas G; Do P; Guizard AV; Desmonts C; Aide N
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):421-428. PubMed ID: 30218317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics based on
    Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
    Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment
    Ahn HK; Lee H; Kim SG; Hyun SH
    Clin Radiol; 2019 Jun; 74(6):467-473. PubMed ID: 30898382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.